Lam Research
LRCX
$258.56
-2.63%
Lam Research Corporation is a global leader in the semiconductor wafer fabrication equipment (WFE) industry, specializing in the critical processes of deposition and etch, which are essential for building and patterning layers on advanced semiconductor chips. The company is a dominant market player, holding the top market share in etch and a clear second position in deposition, and its business is heavily exposed to leading memory chipmakers like Samsung, Micron, and SK Hynix for DRAM and NAND production. The current investor narrative is overwhelmingly focused on Lam's role as a critical infrastructure provider for the AI boom, with recent news highlighting massive capital expenditure plans from customers like Micron to meet AI-driven memory demand, positioning Lam for sustained growth as chipmakers expand capacity.…
LRCX
Lam Research
$258.56
Related headlines
Investment Opinion: Should I buy LRCX Today?
Rating: Hold. The core thesis is that Lam Research is a high-quality company riding a powerful secular trend, but its risk/reward profile is balanced at current levels after a massive rally, warranting caution rather than new aggressive buying.
The Hold rating is anchored by the consensus Buy analyst sentiment but tempered by valuation concerns. Supporting evidence includes the robust 22.14% YoY revenue growth, exceptional profitability (29.06% net margin), fortress balance sheet (D/E of 0.48), and strong cash generation ($6.66B FCF). However, the primary valuation metric, the forward P/E of 37.50x, prices in near-perfect execution of the AI growth story, leaving little margin for error. The PEG ratio of 0.54 suggests growth is reasonably priced, but this relies on forward estimates being met.
The two biggest risks that could invalidate this Hold thesis are: 1) A deceleration in quarterly revenue growth below 15% YoY, signaling a cooling capex cycle, and 2) Multiple compression dragging the forward P/E below 30x on no company-specific news, reflecting a broader de-rating of growth stocks. This Hold would upgrade to a Buy on a pullback to the $220-$230 range (roughly a 15% decline) where the valuation better accounts for cyclical risks, or if forward earnings estimates are revised significantly higher. It would downgrade to a Sell if revenue growth turns negative or gross margins contract below 45%. Relative to its own history and the growth it embodies, the stock is fairly valued to slightly overvalued, demanding flawless execution to justify further multiple expansion.
Sign up to view all
LRCX 12-Month Price Forecast
The AI assessment is neutral based on a balanced risk/reward at current prices. Lam Research's fundamentals are undeniably strong, and it is a critical enabler of AI infrastructure. However, the stock's 319% run-up and premium valuation have likely priced in much of the near-term optimism. The base case (50% probability) of steady growth and range-bound trading is most likely. The stance would upgrade to bullish on a pullback that improves the margin of safety or on clear evidence of upward revisions to the multi-year capex cycle. It would turn bearish on any indication that the current growth trajectory is faltering, given the high valuation sensitivity.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Lam Research's 12-month outlook, with a consensus price target around $336.13 and implied upside of +30.0% versus the current price.
Average Target
$336.13
10 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
10
covering this stock
Price Range
$207 - $336
Analyst target range
Lam Research is covered by at least 10 analysts, and the institutional sentiment is overwhelmingly bullish, as evidenced by recent ratings from major firms including Buy ratings from Goldman Sachs, UBS, Stifel, and Needham, and Overweight/Outperform ratings from Wells Fargo and RBC Capital. The consensus recommendation is a Buy, and while a specific average target price is not provided in the data, the high level of institutional support and the stock's performance relative to the market imply significant implied upside is embedded in analyst models. The target price range among analysts is likely wide, reflecting differing assumptions about the duration and magnitude of the current semiconductor equipment upcycle; the high-end targets would assume sustained multi-year growth from AI and memory investments, while low-end targets would factor in potential cyclical downturns or margin compression. The lack of recent downgrades and the cluster of reaffirmed bullish ratings following the January 2026 earnings report signal strong analyst conviction in the near-to-medium term story.
Bulls vs Bears: LRCX Investment Factors
The evidence currently leans decisively bullish, driven by Lam Research's fundamental role in the AI infrastructure build-out, exceptional financial performance, and powerful price momentum. The bull case is supported by concrete data: 22% revenue growth, 29% net margins, $6.66B in annual FCF, and a PEG ratio suggesting growth is not fully priced. However, the bear case presents severe and non-trivial risks, primarily centered on valuation and cyclicality. The single most important tension in the investment debate is whether the current AI-driven capital expenditure surge represents a sustainable multi-year paradigm shift or a cyclical peak that will inevitably correct. The resolution of this tension—through either sustained order growth or early signs of a downturn—will determine if the stock's premium valuation is justified or presages a major drawdown.
Bullish
- Dominant AI Infrastructure Play: Lam Research is a direct beneficiary of massive AI-driven capital expenditure, with customers like Micron announcing huge spending plans. The company holds the top market share in etch and clear second in deposition, critical processes for advanced chip manufacturing. This structural demand tailwind is reflected in its 22.14% YoY revenue growth and accelerating quarterly revenue from $5.17B to $5.34B.
- Exceptional Profitability & Cash Flow: The company exhibits superior operational efficiency with a gross margin of 49.6% and a net margin of 29.06% in its latest quarter. It generates massive free cash flow ($6.66B TTM), enabling aggressive shareholder returns, including $1.47B in share repurchases in Q2 2026 alone. This financial strength is underpinned by a robust balance sheet with a current ratio of 2.21 and a manageable debt-to-equity of 0.48.
- Strong Momentum & Technical Uptrend: LRCX is in a powerful uptrend, up 319.70% over the past year and 19.09% in the last month, significantly outperforming the SPY. The stock trades at 98% of its 52-week high ($273.50), indicating sustained bullish conviction. Recent price action shows strong acceleration without meaningful technical divergence, suggesting continued momentum.
- Overwhelmingly Bullish Analyst Sentiment: The stock is covered by at least 10 analysts with a consensus Buy rating, supported by recent upgrades and reaffirmations from major firms like Goldman Sachs and UBS. This institutional conviction is based on the AI-driven multi-year growth cycle for semiconductor equipment. The lack of downgrades following strong earnings signals confidence in the near-term trajectory.
Bearish
- Extreme Cyclical & Valuation Risk: As a semiconductor equipment stock with a beta of 1.79, LRCX is highly sensitive to industry cycles and market sentiment. The forward P/E of 37.50x embeds exceptionally high growth expectations, leaving the stock vulnerable to multiple compression if the AI capex cycle shows any signs of slowing. A reversion to its 52-week low P/E multiples would imply significant downside from current levels.
- Technical Overextension Near All-Time High: Trading at 98% of its 52-week high after a parabolic 319% gain, the stock is at risk of a sharp technical pullback. The high beta of 1.79 means any market-wide risk-off move could trigger a disproportionate sell-off. Support is distant at the March 2026 low of ~$199.93, representing a potential -25% correction from the current price.
- Concentration in Memory & Cyclical Customers: Lam's business is heavily exposed to memory chipmakers (Samsung, Micron, SK Hynix) for DRAM and NAND, which are historically more cyclical than logic/foundry segments. A downturn in memory pricing or capex would directly and significantly impact revenue, as seen in past industry cycles. This concentration amplifies operational risk despite the current AI-driven boom.
- Macro & Geopolitical Sensitivity: Recent news highlights geopolitical tensions reigniting inflation fears, which punish high-multiple growth stocks. As a global company, LRCX faces risks from trade restrictions, supply chain disruptions, and regional instability. Its high valuation makes it particularly susceptible to rising interest rates, which compress the present value of future earnings.
LRCX Technical Analysis
Lam Research is in a powerful, sustained uptrend, evidenced by a staggering 319.70% gain over the past year, with the current price of $267.60 sitting at approximately 98% of its 52-week high of $273.50, indicating the stock is trading near its peak momentum. This positioning near the highs suggests strong bullish conviction but also raises the risk of overextension and potential for a technical pullback if momentum falters. Recent short-term momentum is exceptionally strong and accelerating, with a 19.09% gain over the past month and a 20.02% gain over three months, both significantly outpacing the broader market (SPY up 7.36% and 2.67% respectively), confirming the uptrend's strength without meaningful divergence. The stock's high beta of 1.79 signals it is approximately 79% more volatile than the market, which is typical for a cyclical semiconductor equipment stock and necessitates larger risk tolerance for investors. Key technical levels are clear, with immediate resistance at the 52-week high of $273.50 and support at the 52-week low of $61.14; a decisive breakout above resistance could signal a continuation of the parabolic move, while a breakdown below recent support around the $200 level (from the March 2026 pullback) would suggest a deeper correction is underway.
Beta
1.79
1.79x market volatility
Max Drawdown
-24.2%
Largest decline past year
52-Week Range
$68-$274
Price range past year
Annual Return
+287.5%
Cumulative gain past year
| Period | LRCX Return | S&P 500 |
|---|---|---|
| 1m | +8.3% | +8.5% |
| 3m | +18.6% | +2.8% |
| 6m | +70.5% | +4.6% |
| 1y | +287.5% | +32.3% |
| ytd | +39.7% | +3.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LRCX Fundamental Analysis
Lam Research is exhibiting robust revenue growth and margin expansion, with its most recent quarterly revenue (Q2 2026) reaching $5.34 billion, representing a 22.14% year-over-year increase, and a sequential trend showing revenue grew from $5.17 billion in Q4 2025 to $5.32 billion in Q1 2026 and then to $5.34 billion in Q2 2026, indicating sustained demand. The company's profitability is exceptional, with net income of $1.59 billion in the last quarter and a gross margin of 49.6%, while operating margins have remained healthy and stable in the mid-30% range (33.87% in Q2 2026), demonstrating strong operational efficiency and pricing power in a competitive industry. Financially, Lam is a cash-generating powerhouse with a trailing twelve-month free cash flow of $6.66 billion, a robust current ratio of 2.21, and a manageable debt-to-equity ratio of 0.48, providing ample liquidity to fund growth, continue substantial share repurchases ($1.47 billion in Q2 2026), and pay dividends while maintaining a fortress balance sheet.
Quarterly Revenue
$5.3B
2025-12
Revenue YoY Growth
+0.22%
YoY Comparison
Gross Margin
+0.49%
Latest Quarter
Free Cash Flow
$6.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LRCX Overvalued?
Given Lam Research's substantial net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 23.36x and a forward PE of 37.50x, with the significant premium on the forward multiple reflecting the market's high expectations for continued earnings growth driven by the AI investment cycle. Compared to sector averages (data not available in the provided set for a precise industry PE), Lam's valuation is likely at a premium, justified by its market-leading position, superior profitability (net margin of 29.06%), and direct exposure to the high-growth AI infrastructure build-out. Historically, Lam's current trailing PE of 23.36x sits well below its own historical peaks seen in recent quarters, such as the 34.75x recorded in Q2 2026, suggesting the recent massive price appreciation has been supported by even faster earnings growth, though it remains elevated compared to levels seen in 2023 and early 2024, indicating the market is pricing in a strong future but not at the most extreme historical multiples.
PE
23.4x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 9x~35x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
19.5x
Enterprise Value Multiple
Investment Risk Disclosure
Lam Research faces significant financial and operational risks rooted in its cyclicality and customer concentration. While current financials are stellar, with a 29.06% net margin and strong cash flow, the company's revenue is heavily concentrated in the memory semiconductor sector, which is historically volatile. A downturn in memory capex, as seen in past cycles, would directly pressure the 22% YoY revenue growth and compress the premium 49.6% gross margin. The balance sheet is strong now, but the business model is inherently capital-intensive and tied to customer investment cycles, creating earnings volatility risk.
Market and competitive risks are elevated. The stock trades at a forward P/E of 37.50x, a premium multiple that assumes the AI investment cycle will continue unabated for years. This leaves it vulnerable to valuation compression if growth expectations moderate or if interest rates remain elevated, punishing growth stocks. The high beta of 1.79 confirms its sensitivity to broader market swings. Competitively, while Lam holds leadership in etch, rivals like Applied Materials are also forecasting strong growth, indicating a fight for market share that could pressure pricing. Geopolitical news highlighting inflation risks directly threatens high-multiple stocks like LRCX.
The worst-case scenario involves a simultaneous downturn in the memory semiconductor cycle and a broader market correction. This could trigger a chain where customers delay or cancel equipment orders, leading to missed revenue estimates, margin contraction, and a cascade of analyst downgrades. The stock's high valuation would amplify the fall. Realistic downside could see a re-test of the March 2026 low of ~$199.93, a -25% decline from the current $267.60, or even a move toward the 52-week low of $61.14 if a severe cyclical downturn materializes, though that extreme scenario is less probable in the 12-month horizon. Investors must be prepared for a potential loss of 25-35% in an adverse scenario.
FAQ
The key risks are, in order of severity: 1) Cyclical/Valuation Risk: The forward P/E of 37.50x is vulnerable to compression if the AI capex cycle slows, potentially triggering a sharp decline. 2) Customer Concentration Risk: Heavy exposure to cyclical memory chipmakers (Samsung, Micron) means revenue is tied to their volatile investment cycles. 3) Operational Risk: Intense competition from Applied Materials and others could pressure the premium 49.6% gross margin. 4) Macro/Volatility Risk: With a beta of 1.79, the stock is highly sensitive to broader market downturns and interest rate changes, as recent geopolitical news has highlighted.
The 12-month forecast presents three scenarios. The Base Case (50% probability) sees the stock trading between $260 and $290, driven by steady execution on AI-driven growth and stable valuations. The Bull Case (30% probability) projects a breakout to $300-$350 on accelerated capex and multiple expansion. The Bear Case (20% probability) warns of a correction to $190-$230 on signs of a cyclical peak or macro headwinds. The base case is most likely, assuming the current growth trajectory continues as analysts expect. The key assumption is that AI-related semiconductor equipment demand remains robust through 2026.
LRCX appears fairly valued to slightly overvalued based on current metrics. Its trailing P/E of 23.36x is reasonable given its growth and profitability, but the forward P/E of 37.50x indicates the market is pricing in several years of robust earnings growth. The PEG ratio of 0.54 suggests the growth may be reasonably priced relative to expectations. However, compared to its own historical P/E peak of 34.75x, the current forward multiple is at a premium, implying high expectations. The valuation is not egregious given the AI tailwinds, but it leaves little room for error, placing it in a fair value zone that demands perfect execution.
LRCX is a good buy for investors who already have a high-risk tolerance and are seeking exposure to the AI infrastructure theme, but it is not an ideal entry point for new money after its 319% surge. The stock offers strong fundamentals, including 22% revenue growth and 29% net margins, but trades at a demanding forward P/E of 37.50x. The biggest downside risk is a cyclical downturn or valuation compression, which could lead to a -25% drawdown. It is a good buy on a significant pullback (e.g., below $230) for long-term holders, but current levels warrant a Hold stance for most investors.
LRCX is primarily suitable for long-term investors with a minimum 3-5 year horizon who can endure significant volatility. Its cyclical nature means short-term trading is extremely risky due to its high beta of 1.79 and sensitivity to industry news flow. Long-term holders can benefit from the secular growth of semiconductor complexity and AI, but must be prepared for potentially deep drawdowns during industry downturns. The company's strong cash flow and share repurchase program support long-term value creation. For most investors, a long-term, buy-and-hold strategy with periodic rebalancing is recommended over short-term speculation.